Germany Over The Counter (OTC) Analgesics Market Report 2022 to 2030

Germany Over The Counter (OTC) Analgesics Market Analysis

$ 3999

This report presents a strategic analysis of the Germany Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Germany Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.

ID: IN10DEON003 CATEGORY: OTC & Nutraceuticals GEOGRAPHY: Germany

Buy Now

Germany Over the Counter (OTC) Analgesics Market Executive Summary

In Europe, Germany is one of the countries with the highest healthcare expenditures, accounting for 11.1% of GDP on average. In the Covid year of 2020, health spending in Germany reached a new high of 440.6 billion euros or 5,298 euros per person. 13.1% of the country's GDP was spent on healthcare in 2020. (GDP). This percentage increased by 1.2 percentage points over the previous year.

In 2022, it is anticipated that the Health Care segment's revenue will amount to US$1,645.00m. Revenue is anticipated to rise at an average yearly rate of 18.45% (CAGR 2022-2025), with a predicted market size of US$2,734.00m by 2025. By 2025, there will likely be 22.6 million users in the healthcare segment. User penetration is anticipated to reach 27.1% by 2025 and will be 24.1% in 2022. It is anticipated that the average revenue per user (ARPU) will be US$81.50.

Analgesic is a term that refers to a group of medications that are used to relieve pain without causing loss of consciousness. Opioid analgesics have been widely accepted as the most effective and widely utilized medications for the treatment of severe pain all over the world.

The global demand for analgesics arises from the goal of improving healthcare outcomes. Pain management, for example, necessitates a multidisciplinary approach to provide. Aside from that, manufacturers' creation of opioid analgesics with abuse-deterrent qualities has resulted in a significant demand for analgesics all over the world.

Only approximately 14% of the world's population receives palliative care, according to the WHO. Furthermore, it is estimated that approximately 40 million people worldwide require palliative care each year. Over 78 percent of that population is found in low- and middle-income countries.

The rise in the global prevalence of neuropathic and chronic pain, as well as developments in pain treatment strategies, are driving global analgesics sales.

Market Size and Key Findings

The Germany Over the Counter (OTC) Analgesics Market size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.

Germany Over the Counter (OTC) Analgesics Market Size (In USD Bn) (2021-2030F)

Market Dynamics

Market Growth Drivers Analysis

The rise in self-medication during the predicted period is one of the major drivers of market expansion. The market is expanding as a result of more people moving from prescription to over-the-counter medications due to lower costs and an increase in OTC medicine approvals from regulatory bodies.

For instance, Sanofi declared in February 2017 that Xyzal Allergy 24HR, an over-the-counter medication for seasonal allergies, had received FDA approval. The industry is expanding due to the accessibility and affordability of OTC products as well. For instance, it was estimated in the National Center for Biotechnology Information (NCBI) publication that each year, over-the-counter medications save the United States over USD 100.0 billion. During the anticipated term, the aforementioned elements would accelerate market expansion.

Competitive Landscape

Key Players

The prominent players operating in this market include Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland), Sanofi (France), Pfizer (USA), GlaxoSmithKline Plc (UK), Bohringer Ingelheim International GmbH (Germany), Reckitt Benckiser Group Plc (UK), Takeda Pharmaceuticals (Tokyo), etc.

1. Executive Summary
1.1 Product Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Government Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel and Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Over the Counter (OTC) Analgesics Market Segmentation

The Over the Counter (OTC) Analgesics Market is segmented as mentioned below:

By Product (Revenue, USD Billion):

Analgesics
Cold & Cough Remedies
Digestive and Intestinal Remedies
Skin Treatments Sports Nutrition

By Distribution Channel (Revenue, USD Billion):

Drug Stores and Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.